本報告已在2012年03月14日停止出版。
更改為出版
Implantable Medical Devices to 2015
出版日期 : 2012年03月
商品編碼: 234022
美國體內植入型醫療儀器之需求於2009年創下了323億美金之紀錄。同市場預計將以年率8.3%成長,2014年將達到480億美金之規模。
本報告為,提供美國體內植入型醫療儀器市場之醫療儀器類型別需求實績(1999年、2004年、2009年)及需求預測(2014年、2019年),並匯整主要企業之簡介,以下列摘要形式闡述。
簡介
第1章 實施概要
第2章 市場環境
- 泛論
- 經濟展望
- 人口模式
- 醫療趨勢
- 健康保險
- 慢性病之情況
- 急性病之情況
- 國家之醫療支出
- 醫療供應商
- 患者處置
- 醫療產品市場
第3章 產品概要
- 泛論
- 植入程序
- 植入材料及組件
- 法規問題
- 過去市場實績
- 價格趨勢
- 美國貿易
- 國際市場
第4章 整形外科植入
- 泛論
- 市場概要
- 產品概要
- 關節重建
- 脊柱植入
- 骨生物活性材料
- 外傷植入
第5章 心臟植入
- 泛論
- 市場概要
- 產品概要
- 心臟節律器
- 植入型心律轉複除顫器
- 心臟電擊節律器
- 心律調節器
- 心律調節配件
- 心臟支架及相關植入
- 結構性心臟植入
第6章 其他植入型醫療儀器
- 泛論
- 市場概要
- 產品概要
- 神經刺激器
- 眼科植入
- 乳房植入
- 藥物植入
- 尿道植入
- 人工植入
- 皮膚植入
- 其他植入型醫療儀器
第7章 產業結構
- 泛論
- 市場佔有率
- 競合策略
- M&A
- 授權、協定
- 研究開發
- 行銷及通路
- 製造
企業簡介
圖表
Abstract
US medical implant demand to increase 8.3% annually through 2014
US demand for implantable medical devices will increase 8.3 percent annually
to $48 billion in 2014. Although weakened in the past few years by product
recalls and safety controversies, especially in the cardiac implant segment,
growth will remain strong. The development of next generation devices based on
new technologies and improved materials will rectify recent performance
problems experienced by implantable cardiac rhythm devices and lessen the
thrombosis risk of drug-eluting coronary stents. Shortcomings in existing drug
therapies will promote the increasing use of implantable devices in the
treatment and management of cardiovascular, orthopedic, neurological,
ophthalmic and various other chronic disorders.
Orthopedic implants to remain dominant segment
US demand for orthopedic implants will increase 8.8 percent annually to nearly
$26 billion in 2014, with the four major product segments -- reconstructive
joint replacements, spinal implants, orthobiologics and trauma implants -- all
providing strong growth opportunities. The market for reconstructive joint
replacements, which is forecast to reach $10.5 billion in 2014, will gain
upward momentum from an aging population and the widespread prevalence of
physically active lifestyles. These trends will expand the number of persons
suffering from degenerative and injured joints, especially deteriorated knees
and hips.
CRT devices to be fastest growing cardiac implant
Demand for cardiac implants in the US is projected to increase 7.3 percent
annually to $16.7 billion in 2014. Based on breadth of indications served,
pacing devices will remain the top-selling group of cardiac implants. Cardiac
resynchronization therapy (CRT) devices will post the fastest growth among
pacing devices as they greatly improve therapeutic outcomes in patients
afflicted with congestive heart failure. Advantages over anti-arrhythmia drugs
will keep implantable cardioverter defibrillators (ICDs) the preferred
treatment for tachycardia. Improvements in safety and performance properties
will enable ICDs to recapture growth opportunities lost over the past year to
product recalls. The lack of effective pharmaceuticals for bradycardia will
continue to create a sizeable market for implantable cardiac pacemakers.
Breast implants to exhibit strong growth
Other implantable medical devices are forecast to post demand of $5.7 billion
in 2014, up 9.0 percent annually from 2009. Growth will be led by implantable
stimulators for neurological conditions, brachytherapy for prostate cancer
indications, cochlear devices for restoring hearing loss, and gastric bands
for obesity intervention. These products offer significant performance and
outcome advantages over alternative treatments. Among other implantable
medical devices, silicone gel-filled breast implants and dermal and tissue
implants for cosmetic surgery will fare the best in the marketplace,
reflecting widening popularity among the appearance-conscious population.
Study coverage
This new Freedonia industry study, Implantable Medical Devices, presents
historical demand data (1999, 2004 and 2009) plus forecasts for the years 2014
and 2019 for orthopedic, cardiac and other medical implants by type. The
market environment section reviews trends in health insurance, health
expenditures, medical conditions, medical providers and patient activity. The
industry structure section evaluates company market share and profiles major
US industry competitors, including Abbott Laboratories, Boston Scientific,
Johnson & Johnson, Smith & Nephew, Stryker, and Zimmer.
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Economic Outlook
- Demographic Patterns
- Health Care Trends
- Health Insurance
- Chronic Conditions
- Cardiovascular Conditions
- Orthopedic Conditions
- Other Chronic Conditions
- Acute Conditions
- National Health Expenditures
- Medical Providers
- Acute Care Hospitals
- Physicians
- Outpatient Facilities
- Skilled Nursing Homes
- Patient Activity
- Hospital Activity
- Surgical Procedures
- Outpatient Consultations
- Medical Product Markets
- Pharmaceuticals & Biologicals
- Surgical Appliances & Supplies
- Surgical & Medical Instruments
- Electromedical Equipment
- Other Medical Products
III. PRODUCT OVERVIEW
- General
- Implant Procedures
- Orthopedic Procedures
- Heart-Related Procedures
- Other Implant Procedures
- Implant Materials & Components
- Microelectronic Components
- Specialty Metals
- Polymers
- Elastomers
- Other Materials
- Pharmaceuticals & Biologicals
- Ceramics
- Collagen
- All Other Materials
- Regulatory Considerations
- Historical Market
- Pricing Trends
- US Trade
- International Markets
IV. ORTHOPEDIC IMPLANTS
- General
- Market Outlook
- Product Overview
- Reconstructive Joint Replacements
- Knee Replacements
- Types of Knee Replacements
- Fixed Bearing Implants
- Rotating Platform Implants
- Unicondylar Implants
- Cemented & Cementless Knee Replacements
- Producers
- Hip Replacement Implants
- Metal-on-Plastic Hip Replacements
- Metal-on-Metal Hip Replacements
- Ceramic-on-Ceramic Hip Replacements
- Producers
- Other Reconstructive Joint Replacements
- Shoulder Implants
- Types of Shoulder Implants
- Producers
- Elbow Implants
- Ankle Implants
- All Other Reconstructive Joint Replacements
- Spinal Implants
- Thoracolumbar Implants
- Intervertebral Spacers
- Non-Bone Implants
- Machined Allografts
- Motion Preservation Devices
- Cervical Implants
- Implantable Spinal Stimulators
- Orthobiologics
- Hyaluronic Acid
- Bone Substitutes
- Bone Growth Factors
- Bone Cement
- Tissue Implants
- Trauma Implants
- Internal Fixation Devices
- Craniomaxillofacial Implants
- Implantable Trauma Stimulators
V. CARDIAC IMPLANTS
- General
- Market Outlook
- Product Overview
- Pacing Devices
- Implantable Cardioverter Defibrillators (ICDs)
- Technology & Applications
- Producers & Products
- Cardiac Resynchronization Therapy Devices (CRT-Ds)
- Technology & Applications
- Producers & Products
- Implantable Cardiac Pacemakers (ICPs)
- Technology & Applications
- Producers & Products
- Pacing Accessories
- Pacing Leads
- Technology
- Producers & Products
- Pacing Batteries
- Cardiac Stents & Related Implants
- Coronary Stents
- Drug-Eluting Stents
- Bare-Metal Stents
- Peripheral Stents
- Endovascular Stent-Grafts
- Renal & Related Stents
- Femoral & Related Stents
- Carotid Stents
- Stent-Related Implants
- Synthetic Grafts
- Vascular Grafts
- Peripheral Grafts
- Vena Cava Filters
- Structural Cardiac Implants
- Heart Valves & Accessories
- Tissue Heart Valves
- Types of Tissue Heart Valves
- Producers & Products
- Mechanical Heart Valves
- Heart Valve Repair Devices
- Procedures & Products
- Producers
- Ventricular-Assist Devices
- Technology
- Producers & Products
- Implantable Heart Monitors
- Insertable Loop Recorders (ILRs)
- Implantable Hemodynamic Monitors (IHMs)
VI. OTHER IMPLANTABLE MEDICAL DEVICES
- General
- Market Outlook
- Product Overview
- Neurological Stimulators
- Technology
- Producers & Products
- Medtronic
- St. Jude Medical
- Cyberonics
- Ophthalmic Implants
- Intraocular Lenses (IOLs)
- Glaucoma & Other Ophthalmic Implants
- Glaucoma & Related Implants
- Retinal Implants
- Breast Implants
- Types of Breast Implants
- Producers
- Drug Implants
- Drug Inserts
- Brachytherapy Products
- Implantable Drug Pumps
- Urological Implants
- Biliary Stents
- Penile Implants
- Other Urological Implants
- Cochlear Implants
- Dermal Implants
- All Other Implantable Medical Devices
- Gastric Bands
- Airway & Esophageal Stents
- Miscellaneous Devices
VII. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Medtronic
- Johnson & Johnson
- Boston Scientific
- Stryker
- St. Jude Medical
- Zimmer Holdings
- Synthes
- Abbott Laboratories
- Biomet
- Smith & Nephew
- Other Companies
- Mergers & Acquisitions
- Licensing & Related Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing
COMPANY PROFILES
- Abbott Laboratories
- Abbott Spine, see Zimmer Holdings
- ABIOMED Incorporated
- Advanced Medical Optics, see Abbott Laboratories
- Aesculap Implant Systems, see Braun (B.) Melsungen
- Allergan Incorporated
- Altiva, see Exactech
- American Medical Systems Holdings Incorporated
- Angiotech Pharmaceuticals Incorporated
- Arbor Surgical Technologies Incorporated
- Bard (CR) Incorporated
- Bausch & Lomb Incorporated
- Biomet Incorporated
- Biophan Technologies Incorporated
- Blackstone Medical, see Orthofix International
- Boston Scientific Corporation
- Braun (B.) Melsungen AG
- Cochlear Limited
- Conor Medsystems, see Johnson & Johnson
- Cook Group Incorporated
- Cordis, see Johnson & Johnson
- CoreValve, see Medtronic
- Davol, see Bard (CR)
- DePuy, see Johnson & Johnson
- DJO Incorporated
- Edwards Lifesciences Corporation
- EndoArt, see Allergan
- Endologix Incorporated
- Ethicon Endo-Surgery, see Johnson & Johnson
- Ethicon Incorporated, see Johnson & Johnson
- Exactech Incorporated
- Genzyme Corporation
- Gore (WL) & Associates Incorporated
- INBONE Technologies, see Wright Medical Group
- Johnson & Johnson
- Kyphon, see Medtronic
- Medtronic Incorporated
- Mentor, see Johnson & Johnson
- Orthofix International NV
- Orthovita Incorporated
- Osteotech Incorporated
- Pioneer Surgical Technology Incorporated
- Regeneration Technologies, see RTI Biologics
- RTI Biologics Incorporated
- Serica Technologies, see Allergan
- Smith & Nephew plc
- Sorin SpA
- St. Jude Medical Incorporated
- Stryker Corporation
- Synthes Incorporated
- Terumo Corporation
- Thoratec Corporation
- Tutogen Medical, see RTI Biologics
- Visiogen, see Abbott Laboratories
- Vitatron, see Medtronic
- Wright Medical Group Incorporated
- Zimmer Holdings Incorporated
- Other Companies Mentioned in Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population by Age Group
- 3 Health Insurance Coverage of the US Population, 1999-2009
- 4 Chronic Conditions by Type
- 5 Cardiovascular Conditions by Type
- 6 Orthopedic Conditions by Type
- 7 Acute Conditions by Type
- 8 National Health Expenditures by Type & Source
- 9 Medical Providers by Type
- 10 Patient Activity by Type
- 11 Medical Product Demand by Type
SECTION III -- PRODUCT OVERVIEW
- 1 Implantable Medical Devices Demand by Product Group
- 2 Medical Implant Procedures by Type
- 3 Implantable Medical Devices Materials & Components Demand by Type
- 4 Implantable Medical Devices - Historical Market, 1999-2009
- 5 US Trade in Implantable Medical Devices
- 6 World Implantable Medical Devices Demand by Region
SECTION IV -- ORTHOPEDIC IMPLANTS
- 1 Orthopedic Implants Demand by Product Group
- 2 Reconstructive Joint Replacements Demand by Type
- 3 Reconstructive Knee Replacements Demand by Type
- 4 Reconstructive Hip Replacements Demand by Type
- 5 Other Reconstructive Joint Replacements Demand by Product Group
- 6 Spinal Implants Demand by Product Group
- 7 Thoracolumbar Implants Demand by Application
- 8 Intervertebral Spacers Demand by Type
- 9 Motion Preservation Devices Demand
- 10 Cervical Implants Demand by Application
- 11 Implantable Spinal Stimulators Demand
- 12 Orthobiologics Demand by Product Group
- 13 Hyaluronic Acid Demand
- 14 Bone Substitutes Demand
- 15 Bone Growth Factors Demand
- 16 Bone Cement Demand
- 17 Tissue Implants Demand
- 18 Trauma Implant Devices Demand by Product Group
- 19 Internal Fixation Devices Demand by Application
- 20 Craniomaxillofacial Implants Demand
- 21 Implantable Trauma Stimulators Demand
SECTION V -- CARDIAC IMPLANTS
- 1 Cardiac Implants Demand by Product Group
- 2 Pacing Devices Demand by Product Group
- 3 Implantable Cardioverter Defibrillators (ICDs) Demand by Type
- 4 Chronic Resynchronization Therapy Devices (CRT-Ds) Demand
- 5 Implantable Cardiac Pacemakers (ICPs) Demand by Type
- 6 Pacing Accessories Demand by Product Group
- 7 Cardiac Stents & Related Implants Demand by Product Group
- 8 Coronary Stents Demand by Type
- 9 Drug-Eluting Coronary Stents Demand
- 10 Bare-Metal Coronary Stents Demand
- 11 Peripheral Stents Demand by Product Group
- 12 Endovascular Stent-Grafts Demand
- 13 Renal & Related Stents Demand
- 14 Femoral & Related Stents Demand
- 15 Carotid Stents Demand
- 16 Stent-Related Implants Demand by Product Group
- 17 Synthetic Grafts Demand
- 18 Vena Cava Filters Demand
- 19 Structural Cardiac Implants Demand by Product Group
- 20 Heart Valves & Related Accessories Demand by Type
- 21 Ventricular-Assist Devices (VADs) Demand
- 22 Implantable Heart Monitors Demand
SECTION VI -- OTHER IMPLANTABLE MEDICAL DEVICES
- 1 Other Implantable Medical Devices Demand by Product Group
- 2 Implantable Neurological Stimulators Demand
- 3 Ophthalmic Implants Demand by Product Group
- 4 Breast Implants Demand by Type
- 5 Drug Implants Demand by Type
- 6 Urological Implants Demand by Product Group
- 7 Cochlear Implants Demand
- 8 Dermal Fillers Demand by Type
- 9 All Other Implantable Medical Devices Demand by Type
SECTION VII -- INDUSTRY STRUCTURE
- 1 US Implantable Medical Devices Sales by Company, 2009
- 2 Selected Acquisitions & Divestitures
- 3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- PRODUCT OVERVIEW
- 1 Implantable Medical Devices Demand by Product Group, 2009
- 2 Implantable Medical Devices - Materials & Components Demand, 2009
SECTION IV -- ORTHOPEDIC IMPLANTS
- 1 Orthopedic Implants Demand by Product Group, 2009
- 2 Reconstructive Joint Replacements Demand by Type, 2009
- 3 Spinal Implants Demand by Product Group, 2009
- 4 Orthobiologics Demand by Product Group, 2009
SECTION V -- CARDIAC IMPLANTS
- 1 Cardiac Implants Demand by Product Group, 2009
- 2 Pacing Devices Demand by Product Group, 2009
- 3 Cardiac Stents & Related Implants Demand by Product Group, 2009
SECTION VI -- OTHER IMPLANTABLE MEDICAL DEVICES
- 1 Other Implantable Medical Devices Demand by Product Group, 2009
SECTION VII -- INDUSTRY STRUCTURE
- 1 Implantable Medical Devices - Market Share by Company, 2009
美國的植入式醫療裝置的需求預期至2014年以年成長率8.3%成長
2010年04月23日
日商環球訊息(股)有限公司開始販售美國的市場調查機構The Freedonia Group,所發行的調查報告「Implantable Medical Devices (US industry forecasts for 2014 & 2019) (體內植入型醫療儀器之美國產業預測:2014年、2019年)」。
Freedonia公司表示,「美國的植入式醫療裝置的需求預期以年成長率8.3%成長,至2014年將達490億美元」。由於既有的藥物治療的不足,針對整型外科、心血管障礙、神經疾病、眼疾、以及其他慢性疾病的管理與治療的植入式醫療裝置,將有促進成長的效果。
整形外科用移植的需求預期於2014年達260億美元
整形外科用移植上的需求,在美國的醫療用移植產業上來說,預料還會是最大的市場區塊。此需求被預測將創下年成長率8.8%的紀錄,且有著擁有強勁成長機會的4種主要產品區塊,關節置換重建手術、脊椎移植、外傷移植和骨生物活性材料。關節置換重建手術市場被預期於2014年將達到105億美元。
基礎裝置中呈現最快速成長的CRT(心臟再同步治療)裝置
美國的心臟移植的需求預期將以年成長率7.3%成長,於2014年達到167億美元。Freedonia Group傳達了該訊息,「由於心臟再同步治療(CRT)能大幅改善鬱血性心臟功能不足患者的治療效果,故此CRT裝置在基礎裝置當中,才能成就最快速的成長」。再加上,對於徐脈有成效的醫藥品的不足,會成為今後推動大規模的植入式心臟節律器市場的力量。而植入式去顫器(ICD),由於有勝過抗心律不整藥物的優點,會成為頻脈上所被偏好的治療方式。還有,藉由安全性與表現的改善,植入型去顫器將可重新取回因為前一年的產品召回所喪失掉的市場機會。
US IMPLANTABLE MEDICAL DEVICES DEMAND
(million dollars)
|
| % Annual Growth |
| Item | 2004 | 2009 | 2014 | 2004-2009 | 2009-2014 |
| Implantable Medical Devices Demand | 19870 | 32860 | 49050 | 10.6 | 8.3 |
| Orthopedic Implants | 10290 | 16900 | 25800 | 10.4 | 8.8 |
| Cardiac Implants | 7460 | 12280 | 17600 | 10.5 | 7.5 |
| Other Implantable Medical Devices | 2120 | 3680 | 5650 | 11.7 | 9.0 |
©2010 by The Freedonia Group, Inc.
|